The Present and Future
Cardiovascular Medicine and Society
COVID-19, Clinical Trials, and QT-Prolonging Prophylactic Therapy in Healthy Subjects: First, Do No Harm

https://doi.org/10.1016/j.jacc.2020.05.008Get rights and content
Under an Elsevier user license
open archive

Key Words

clinical trials
COVID-19
genetics
QT interval
sudden cardiac death

Abbreviations and Acronyms

COVID-19
coronavirus disease-2019
ECG
electrocardiogram

Cited by (0)

The author has reported that he has no relationships relevant to the contents of this paper to disclose.

The author attests they are in compliance with human studies committees and animal welfare regulations of the author's institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC author instructions page.